Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Hemp Definitions topic
No spam. Unsubscribe anytime.
Committee adopts technical fixes to hemp‑product definitions, raises non‑intoxicating cannabinoid limits
Summary
Representative West's oversight bill (House File 12-71) won committee amendments aligning definitions for compliant hemp products and increasing allowed limits for non‑intoxicating cannabinoids; the committee laid the measure over for further consideration.
House File 12-71, an Office of Cannabis Management oversight bill, received technical fixes in committee to align statutory definitions and to adjust permissible levels for certain non‑intoxicating cannabinoids in hemp products as the sector migrates from Chapter 152 into the Chapter 342 structure.
Representative West explained the A1 amendment corrected an improperly cited subdivision; the A2 amendment aligned the definition of lower‑potency hemp edibles in two sections and increased limits for non‑intoxicating cannabinoids so that products currently sold and shipped nationally would remain legal under Minnesota law. "You can get them shipped to your door, you can buy them today," West said, urging the committee to avoid unnecessarily criminalizing products now commonly sold.
Interim Director Eric Taubel said the bill would also make several retailer and manufacturer requirements consistent across hemp and cannabis licensing schemes and would permit labeling for sublingual application of non‑intoxicating products. Consumer testimony supported broader access: Kayla Fearing, a patient consultant and pharmacy technician, urged the committee to preserve access to non‑intoxicating cannabinoids for therapeutic uses.
The committee adopted the technical A1 and the A2 substantive alignment and laid the bill over for possible inclusion, directing continued review of product definitions and safety labeling.
